What's new? Log in Free sign up

Cresco Labs (CRLBF)

Company Profile

Company profile

Ticker

CRLBF, CL

Exchange

Website

www.crescolabs.com

CEO

Mr. Charles Bachtell

Incorporated

British Columbia, Canada

Location

Fiscal year end

Industry (SIC)

Medicinal Chemicals & Botanical Products

Curaleaf • Ayr Wellness • Jushi • Ascend Wellness • Trulieve Cannabis • USANA Health Sciences • First Trinity Financial • 4Front Ventures • SNDL • Mind Medicine ...

Former names

IBEX Holdings Ltd

SEC CIK

Corporate docs

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

IRS number

981505364

CRLBF stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Unaudited Condensed Interim Consolidated Financial Statements

Current report (foreign)

Cresco Labs Announces Dennis Olis to Retire as Chief Financial Officer

Registration of securities for employees

Unaudited Condensed Interim Consolidated Financial Statements

Cresco Labs Announces Voting Results of Its Annual General and Special Meeting of Shareholders

Notice of Annual General and Special Meeting and Management Information Circular

Unaudited Condensed Interim Consolidated Financial Statements

Annual report (Canada)

Cresco Labs Reports Fourth Quarter & Full Year 2023 Financial Results Demonstrating Significant Profitability and Cash Flow Improvements

Transcripts

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

NOMURA HOLDINGS INC

Cresco Labs / Cresco Labs ownership change

Cresco Labs / Cresco Labs ownership change

Cresco Labs / Cresco Labs ownership change

Cresco Labs / Cresco Labs ownership change

Cresco Labs / Cresco Labs ownership change

Cresco Labs / Cresco Labs ownership change

NOMURA HOLDINGS INC

Cowen Financial Products LLC

Cowen Financial Products LLC

Financial summary

Financial statements Chart CRLBF financial data

Quarter (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Cresco Labs earnings reports.

Institutional ownership, Q3 2024

CRLBF institutional ownership history Ownership history

0.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	7	6	+16.7%
Opened positions	3	3	–
Closed positions	2	0	NEW
Increased positions	0	0
Reduced positions	0	1	EXIT

13F shares	Current	Prev Q	Change
Total value	337.06 mm	155.00 mm	+117.5%
Total shares	211.94 k	109.25 k	+94.0%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
HighPoint Advisor	108.86 k	$164.92 mm	NEW
Albert D Mason	97.05 k	$162.07 mm	0.0%
Winch Advisory Services	3.53 k	$5.90 mm	NEW
Strategic Investment Solutions	1.46 k	$2.43 mm	NEW
Thompson Investment Management	725.00	$1.21 mm	0.0%
Massmutual Trust Co FSB	200.00	$334.00 k	0.0%
McMahon Financial Advisors	114.00	$190.00 k	0.0%

Largest transactions	Shares	Bought/sold	Change
HighPoint Advisor	108.86 k	+108.86 k	NEW
Hantz Financial Services	0.00	-9.01 k	EXIT
Winch Advisory Services	3.53 k	+3.53 k	NEW
Horrell Capital Management	0.00	-2.15 k	EXIT
Strategic Investment Solutions	1.46 k	+1.46 k	NEW
Massmutual Trust Co FSB	200.00	0.00	0.0%
Albert D Mason	97.05 k	0.00	0.0%
Thompson Investment Management	725.00	0.00	0.0%
McMahon Financial Advisors	114.00	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

News

From Benzinga Pro

'President Trump's Endorsement Represents A Sea Change In Cannabis Policy,' Says Trulieve CEO As Advocacy Groups Join Forces

"Our new combined organization will best position the industry to help the President get them over the finish line," says Trulieve CEO Kim Rivers.

Cannabis Stock Movers For January 9, 2025

DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On

DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.

EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'

The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns

Press releases

From Benzinga Pro

Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results

Record quarterly operating cash flow of $49 million and year to date operating cashflow of $103 million, an increase of 66% from the prior year period Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco Labs"

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.